OverviewChartNewsTraderScreen

DZ Bank Call 750 LLY 19.12.2025/  DE000DQ0R4D1  /

EUWAX
9/6/2024  8:04:34 AM Chg.-0.15 Bid11:51:58 AM Ask11:51:58 AM Underlying Strike price Expiration date Option type
3.61EUR -3.99% 3.58
Bid Size: 10,000		 3.60
Ask Size: 10,000		 ELI LILLY 750.00 - 12/19/2025 Call
GlobeNewswire 9/3 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
Newsfile Corp 8/28 The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire 8/27 Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership...
GlobeNewswire 8/26 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 8/21 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 8/21 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 8/19 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 8/14 Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s ...
GlobeNewswire 8/14 Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD...
TeleTrader 8/9 US trades up premarket after yesterday's earnings
TeleTrader 8/8 Wall Street rallies at close, Dow soars 680 pts
GlobeNewswire 8/8 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...
TeleTrader 8/8 US opens higher with data, earnings in focus
GlobeNewswire 8/8 ProQR Announces Second Quarter 2024 Operating and Financial Results
TeleTrader 8/8 Eli Lilly's Q2 revenue jumps 36% to $11.3B
GlobeNewswire 8/8 Defiance Launches LLYX, the First 2X Leveraged Single-Stock ETF on Eli Lilly
TeleTrader 8/8 US down premarket as volatility persists
GlobeNewswire 8/7 Pattern Announces Company Presentation at LSX World Congress USA
GlobeNewswire 8/6 Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...
GlobeNewswire 8/6 SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discov...
GlobeNewswire 8/2 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...
GlobeNewswire 8/1 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 8/1 COUR Pharmaceuticals Announces Leadership Transition for Strategic Growth Objectives
GlobeNewswire 7/31 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders
GlobeNewswire 7/31 MORF Alert: Wohl & Fruchter LLP Files Class Action Lawsuit on Behalf of Shareholders of Morphic Hold...